Insight Inv LLC Purchases Shares of 151 UnitedHealth Group Incorporated (NYSE:UNH)

Insight Inv LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 151 shares of the healthcare conglomerate’s stock, valued at approximately $88,000.

Other institutional investors also recently modified their holdings of the company. International Assets Investment Management LLC boosted its stake in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Lone Pine Capital LLC acquired a new position in UnitedHealth Group in the second quarter worth approximately $480,903,000. Dimensional Fund Advisors LP raised its stake in shares of UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares in the last quarter. Baillie Gifford & Co. boosted its position in UnitedHealth Group by 1,125.4% during the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after purchasing an additional 821,050 shares during the period. Finally, Accredited Investors Inc. lifted its stake in shares of UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after buying an additional 776,516 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 2.5 %

Shares of UnitedHealth Group stock opened at $561.10 on Tuesday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $516.37 billion, a P/E ratio of 36.55, a price-to-earnings-growth ratio of 1.61 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a 50-day simple moving average of $586.36 and a 200 day simple moving average of $559.39.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the previous year, the company posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 27.63 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.50%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday. Cantor Fitzgerald raised their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. UBS Group lowered their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Truist Financial reissued a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Finally, Barclays upped their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $626.84.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.